Ne subnuclear partitioningFigure two. MET1-dependent CG methylation is expected for variant 1-type rRNA gene silencing. (A) rRNA gene variant expression in wild kind (Col-0) or drm2-2, drm1 drm2, cmt3-11, drm1…
Es lining the cavity/tunnel method that, upon mutation to a bigger side chain, may possibly eliminate sections of your channeling apparatus. Using starting points inside the PRODH web page, the…
Product Name : ChloroquineSpecifications & Purity : 10mM in DMSOCAS : 54-05-7Formula: C18H26ClN3Molecular Weight : 319.87MDL number: Synonyms : chloroquine|54-05-7|Aralen|Chlorochin|Chloraquine|Artrichin|Chloroquina|Chloroquinium|Capquin|Reumachlor|Chemochin|Chlorquin|Clorochina|Malaquin|Bemaco|Arthrochin|Bemasulph|Chingamin|Cidanchin|Cocartrit|Dichinalex|Gontochin|Pfizerquine|Quinachlor|QuinercyShipped In: Dry iceIUPAC Name : 4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamineINCHI : InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)InChi Key: WHTVZRBIWZFKQO-UHFFFAOYSA-NCanonical…
Product Name : CimifuginSpecifications & Purity : 10mM in DMSOCAS : 37921-38-3Formula: C16H18O6Molecular Weight : 306.31MDL number: Synonyms : Cimifugin|37921-38-3|Cimitin|(2S)-7-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofurochromen-5-one|C09000|AKOS015896760|AC1L9C0B|CHEBI:3701|GTPL12555|DTXSID10331690|HY-N0634|MFCD23105630|s9028|ZINC04097841|CCG-267533|CS-3794|AC-347Shipped In: Dry iceIUPAC Name : (2S)-7-(hydroxymethyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofurochromen-5-oneINCHI : InChI=1S/C16H18O6/c1-16(2,19)13-5-9-11(22-13)6-12-14(15(9)20-3)10(18)4-8(7-17)21-12/h4,6,13,17,19H,5,7H2,1-3H3/t13-/m0/s1InChi Key: ATDBDSBKYKMRGZ-ZDUSSCGKSA-NCanonical…
Product Name : CefazolinSpecifications & Purity : 10mM in DMSOCAS : 25953-19-9Formula: C14H14N8O4S3Molecular Weight : 454.51MDL number: Synonyms : cefazolin|25953-19-9|Cephazolin|Cefazoline|Cephamezine|Cephazoline|Cefamezin|Cephazolidin|Cefazolin acid|Cefazolina|Cefazolinum|Elzogram|CEZ|Cefazoline |Cefazolinum |Cefazolina |Kefzol|HSDB 3213|CHEBI:474053|UNII-IHS69LShipped In: Dry iceIUPAC Name :…
Product Name : CB-103Specifications & Purity : 10mM in DMSOCAS : 218457-67-1Formula: C15H18N2OMolecular Weight : 242.32MDL number: Synonyms : 218457-67-1|CB-103|5-Amino-2-(4-tert-butylphenoxy)pyridine|6-(4-tert-butylphenoxy)pyridin-3-amine|6-(4-(tert-Butyl)phenoxy)pyridin-3-amine|6-pyridin-3-amine|Q5BB91JL0V|MLS000833648|CB103|5-Amino-2-(4-tertbutylphenoxy)pyridine|6-(4-tShipped In: Dry iceIUPAC Name : 6-(4-tert-butylphenoxy)pyridin-3-amineINCHI : InChI=1S/C15H18N2O/c1-15(2,3)11-4-7-13(8-5-11)18-14-9-6-12(16)10-17-14/h4-10H,16H2,1-3H3InChi Key: WHIWGRCYMQLLAO-UHFFFAOYSA-NCanonical…
Product Name : CVT-313Specifications & Purity : 10mM in DMSOCAS : 199986-75-9Formula: C20H28N6O3Molecular Weight : 400.47MDL number: Synonyms : CVT-313|199986-75-9|Cdk2 Inhibitor III|CVT 313|NG-36|CHEMBL80713|T5490K8I7S|2(bis-(Hydroxyethyl)amino)-6-(4-methoxybenzylamino)-9-isopropyl-purine|2,2′-((9-Isopropyl-6-((4-methoxybenzyl)amino)-9H-purin-2-yl)azanediyl)diethanol|2,2′-((9-isopropyl-6-((4-metShipped In: Dry iceIUPAC Name : 2--9-propan-2-ylpurin-2-yl]amino]ethanolINCHI :…
Product Name : CL-300619Specifications & Purity : 10mM in DMSOCAS : 19819-18-2Formula: C16H14N2OSMolecular Weight : 282.36MDL number: Synonyms : 19819-18-2|(1)Benzothieno(2,3-d)pyrimidin-4(1H)-one, 5,6,7,8-tetrahydro-2-phenyl-|Antiproliferative agent-15|2-Phenyl-5,6,7,8-tetrahydrobenzothienopyrimidin-4(3H)-one|CHEMBL3967244|2-Phenyl-5,6,7,8-tetrahydro(1)benzothieno(2,3-d)pyrimidin-4(1HShipped In: Dry iceIUPAC Name : 2-phenyl-5,6,7,8-tetrahydro-3H-benzothiolopyrimidin-4-oneINCHI : InChI=1S/C16H14N2OS/c19-15-13-11-8-4-5-9-12(11)20-16(13)18-14(17-15)10-6-2-1-3-7-10/h1-3,6-7H,4-5,8-9H2,(H,17,18,19)InChi…
Reduced levels in comparison to other cells in most dimensions, so the three levels are necessary. In information sets that have been pre-cleaned of debris cells, a reduction to two…
Est) and minimum (Test) indicated the top as well as the worst features for each participant based on their accomplished test performances. Subjects 1, two, three, six, 7, and eight…